JANE STREET GROUP, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 302 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$5,492,634
+112.8%
245,426
+161.6%
0.00%0.0%
Q1 2024$2,581,318
-58.6%
93,832
-54.1%
0.00%
-50.0%
Q4 2023$6,228,650
+123.9%
204,285
+132.2%
0.00%
+100.0%
Q3 2023$2,781,833
-66.7%
87,977
-57.1%
0.00%
-66.7%
Q2 2023$8,353,335
+365.0%
204,839
+325.0%
0.00%
+200.0%
Q1 2023$1,796,451
-15.6%
48,201
-21.0%
0.00%0.0%
Q4 2022$2,129,092
+23.0%
61,023
+97.3%
0.00%0.0%
Q3 2022$1,731,000
-16.5%
30,931
-22.8%
0.00%0.0%
Q2 2022$2,073,000
-84.6%
40,050
-78.3%
0.00%
-80.0%
Q1 2022$13,418,000
-31.5%
184,647
+11.5%
0.01%
-16.7%
Q4 2021$19,582,000
-15.4%
165,614
-4.0%
0.01%
-33.3%
Q3 2021$23,149,000
-75.7%
172,561
-70.7%
0.01%
-75.7%
Q2 2021$95,236,000
+475.5%
588,199
+185.3%
0.04%
+362.5%
Q1 2021$16,547,000
-6.1%
206,177
-36.4%
0.01%
-11.1%
Q4 2020$17,625,000
+2693.2%
324,011
+920.1%
0.01%
Q3 2020$631,000
-66.8%
31,762
-64.9%
0.00%
-100.0%
Q2 2020$1,902,00090,4780.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders